Belgium’s PanTera Begins Construction Of Dedicated Actinium-225 Facility
Plant at Mol could begin supplying crucial radioisotope in 2029
Plant at Mol could begin supplying crucial radioisotope in 2029
Cancer-killing actinium-225 in ‘ultra-high demand’
Medical radioisotope holds promise for cancer patients
Belgian and US companies to address supply gap for clinical trials
Fundraising, co-led by a South Korean conglomerate, will help ‘groundbreaking work’
Register free and get full access to NucNet for 14 days. No card required.
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options